Business Context and Reporting Period
Design Therapeutics, Inc. (DSGN) filed a Form 8-K on March 18, 2022, reporting the entry into a material definitive agreement. The Company, an emerging growth company incorporated in Delaware, operates from its principal executive offices in Carlsbad, California.
Key Financial Metrics
This filing does not contain comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only financial data provided relates to the new lease agreement:
- Annual Base Rent (Expansion Premises): Approximately $132,000 initially.
- Rent Escalation: Subject to 3% annual increases in March of each year.
- Additional Costs: Company share of operating expenses and taxes.
- Rent Abatement: Granted through June 15, 2022, with potential additional abatement if the space is not delivered by July 1, 2022.
Material Changes
The Company entered into a First Amendment to its existing Lease Agreement with Crossing Holdings, LLC. Key changes include:
- Space Expansion: Addition of approximately 4,900 square feet of office space to the existing 12,370 square feet.
- Lease Term: The term for the expansion premises runs from March 18, 2022, to August 31, 2027.
- Related Party Transaction: The landlord, Crossing Holdings, LLC, is managed by Pratik Shah, Ph.D., the Company's Executive Chair, co-founder, and Board member.
Outlook, Risks, and Management Commentary
Management anticipates taking possession of the expansion premises no later than July 1, 2022, pending the completion of tenant improvements. The Company retains an option to extend the lease term for the expansion premises under the same terms as the original agreement. The filing notes that the summary is qualified by the full text of the Lease Amendment filed as Exhibit 10.1.
Investor Verification Checklist
- Verify the total square footage and specific location of the expansion premises.
- Confirm the status of tenant improvements and the expected delivery date of July 1, 2022.
- Review the full Lease Amendment (Exhibit 10.1) for detailed terms regarding operating expenses and taxes.
- Assess the impact of the related-party transaction with Crossing Holdings, LLC, on corporate governance.